Stem cells aim to fix torn shoulder tendons

NCT ID NCT07320378

Not yet recruiting Disease control Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase trial tests whether tendon stem cells can help rotator cuff tears heal better after surgery. About 107 adults with small to medium tears will receive either standard repair or repair plus stem cells placed at the injury site. The study will check for side effects and measure shoulder function over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: tendon stem/progenitor cells (TSPCs) delivered on a fibrin glue scaffold
What this could lead to: If it works, this could lead to a treatment that helps tendons heal better after surgery, reducing the risk of re-tear and improving shoulder function.
What could go wrong: This is a very early (Phase 1) trial with only 107 people, so safety and effectiveness are not yet proven. Stem cell therapies can have side effects like infection or abnormal tissue growth.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ROTATOR CUFF TEAR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease of the tendon rotator cuff syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ROTATOR CUFF TENDINOPATHY

More trials for these conditions

Other studies related to the condition(s) this trial covers.